Amador Bioscience, a leading partner for successful new drug development, provides global-standard translational sciences and clinical pharmacology services to clients ranging from cutting-edge biotech start-ups to multinational pharmaceutical companies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/30/21 | $60,000,000 | Series B+ |
Co-win Ventures GL Ventures MSA Capital  | undisclosed |
